Diagnostics is currently driven by Healthcare. The recent article tape shows 8 bullish, 0 bearish, and 2 neutral reads across 4 sources.
Updated 14 Jul 2026, 2:40 pm IST · Sentiment is computed from saved analyzed news and quote snapshots.
Diagnostics has 10 recent analyzed stories in this hub, with a sector bias score of +50. The dominant cluster is Healthcare, and the story breadth is 8 bullish, 0 bearish, and 2 neutral reads.
The most repeated listed names are SUNPHARMA, CUPID, APOLLOHOSP, ZYDUSLIFE, UNIHEALTH. These are the names drawing the most coverage; quote movement, volume, and company-specific context add further reference.
The Indian pharma and healthcare sector is currently seen as a defensive play amidst global market turmoil and is attracting significant foreign investment. Strong domestic demand and an expanding diagnostics market are key drivers.
No negative stock cluster yet.
Economic Times · 1 day ago · 2 min read
Economic Times · 2 days ago · 2 min read
Economic Times · 8 days ago · 2 min read
Mint · 10 days ago · 2 min read
Economic Times · 11 days ago · 2 min read
Diagnostics coverage is leaning bullish across 10 recent stories from 4 sources. The article split is 8 bullish, 0 bearish, and 2 neutral.
The strongest article-driven stock reads in this hub are SUNPHARMA (+70), CUPID (+69), APOLLOHOSP (+63). These scores are based on saved article impact, not a standalone buy signal.
No clear negative stock cluster is available for Diagnostics yet.
Recent Diagnostics coverage is clustering around Healthcare, Diagnostics, Pharmaceuticals.